Akoya Biosciences, Inc. Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Akoya Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q1 2025.
  • Akoya Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2025 was $3.86M, a 30.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Akoya Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $3.86M -$1.71M -30.7% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $4.26M -$4.11M -49.1% Dec 31, 2024 10-Q 2025-05-13
Q3 2024 $4.66M -$4.34M -48.2% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.15M -$4.48M -46.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.57M -$4.62M -45.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $8.37M -$2.42M -22.4% Dec 31, 2023 10-K 2025-03-17
Q3 2023 $9M -$2.3M -20.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $9.63M -$2.06M -17.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $10.2M +$250K +2.52% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.8M Dec 31, 2022 10-K 2024-03-05
Q3 2022 $11.3M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $11.7M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $9.94M Mar 31, 2022 10-Q 2022-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.